|
ROCHE PREPARES TO LAUNCH COVID-19 ANTIBODY TEST SYSTEM article Apr 17, 2020 Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed t... Read More |
CORONAVIRUS PANDEMIC BRINGS HUNDREDS OF U.S. CLINICAL TRIALS TO A HALT article Apr 11, 2020 Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been... Read More |
HOW PHARMA CAN CONTINUE ENGAGING HCPS IN A WORLD GRIPPED BY COVID-19 article Apr 10, 2020 Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education... Read More |
|
|
COMPARING HYDROXYCHLOROQUINE TRIALS article Apr 01, 2020 One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this ... Read More |
DO CLINICAL TRIAL DELAYS MEAN TROUBLE FOR PHARMACEUTICAL STOCKS? article Apr 01, 2020 Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. T... Read More |
CLINICAL SUPPLY AVAILABILITY & SPEED TO STUDY START-UP article Mar 26, 2020 If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the re... Read More |
|
ADVANCE YOUR PHARMA SUPPLY CHAIN PLANNING DURING A PANDEMIC article Mar 20, 2020 One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies.... Read More |
CLINICAL DEVELOPMENT RISKS AND ISSUES IN A COVID-19 WORLD article Mar 20, 2020 Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the lik... Read More |
THE FUTURE OF PHARMA BEYOND BLOCKBUSTERS article Mar 17, 2020 We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop prec... Read More |
TOP SPECIALTY PHARMACY THERAPY AREAS article Mar 16, 2020 Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 b... Read More |
ARTIFICIAL INTELLIGENCE IN PHARMA: UTILISING A VALUABLE RESOURCE article Mar 11, 2020 The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every a... Read More |
|
|
PFIZER WON’T WIN THE CORONAVIRUS PHARMA WAR article Mar 06, 2020 Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any ... Read More |
MERCK’S PATIENT-CENTRIC CLINICAL TRIAL RECRUITING article Mar 04, 2020 Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed h... Read More |
|
|
WHAT TO WATCH IN 2020: NON-SPECIALTY DRUGS article Mar 01, 2020 Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approxim... Read More |
5 PHARMA TRENDS AND THEIR IMPACT ON PACKAGING article Feb 27, 2020 The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main pac... Read More |
PRICING OF DRUGS – AT WHAT COST? article Feb 27, 2020 We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros... Read More |
PHARMACIST ECARE PLAN - THE NEWEST DISRUPTER IN HEALTH DATA EXCHANGE? article Feb 25, 2020 Every member of the health care team shares a common goal of optimizing patient outcomes. Yet each specialty and position of the healthcare team has a unique workflow facilitated by various tools, from an operative report to a progress note. In this regard the pharmacist plays a pivotal function in ... Read More |
TOP PHARMACEUTICAL FIRMS URGE FDA TO ADOPT BLOCKCHAIN FOR DRUG TRACKING article Feb 25, 2020 Leading market participants in the United States pharmaceutical industry, logistics firms, distributors and other stakeholders in the pharma supply chain have come together to publish a report buttressing the need for industry players to adopt blockchain for tracking prescription drugs, following th... Read More |
WHAT ARE THE ADVANTAGES OF PCD PHARMA COMPANY? article Feb 17, 2020 PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the bus... Read More |
TIPS FOR MANAGING CHRONIC PAIN BEYOND PRESCRIPTION PAINKILLERS article Feb 17, 2020 Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to... Read More |
|
WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST article Feb 11, 2020 The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fil... Read More |
CANCER DRUGS ARE THE MOST PROFITABLE FOR BIG PHARMA article Feb 07, 2020 The pharmaceutical industry's top earners are cancer drugs a sentence that will be read to the surprise of no one. When sussing out why oncological therapies cost so much, the usual suspect is research and development (R&D). It takes years to develop a drug, deep pockets to fund that develop... Read More |
BACTERIAL EVOLUTION OF ANTIBIOTIC ARSENALS PROVIDES NEW DRUG BLUEPRINTS article Feb 07, 2020 Scientists from Trinity College Dublin have discovered that two very different species of bacteria have evolved distinct, powerful antibiotic arsenals for use in the war against their bacterial neighbours. By blueprinting precisely how the antibiotics function against methicillin-resistant Staphyloc... Read More |
|
WILL PHARMA’S RECORD-BREAKING RACE FOR A CORONAVIRUS VAX PAY OFF? article Feb 04, 2020 If a pharma company succeeded in developing a vaccine for the coronavirus in the timeframe many have promised, it would be a historic milestone for the industry. Since cases of the novel coronavirus in China were first reported over a month ago, the pharma world has been mobilizing at a breakneck sp... Read More |
CAN WE USE MEDICINES DESIGNED BY AI ON HUMANS JUST YET article Feb 03, 2020 Artificial intelligence has been assisting humans in finding patterns in biological data in order to predict potential diseases. In a few cases, it is even outperforming prominent doctors in determining the ailments. However, with the latest advancements, pharma companies have turned towards AI to e... Read More |
HOW BIG PHARMA AND STARTUPS CAN LEARN FROM EACH OTHER article Nov 15, 2019 The way to accelerate benefit to patients changes over time as technology improves and innovation becomes more cutting edge. I’ve always looked for the more cutting-edge projects because, quite frankly, they’re just more intellectually stimulating for me. I like being on the vanguard whe... Read More |
THE MARKET FOR UNBORN CHILDREN: BIG PHARMA, VACCINES AND TRAFFICKING OF ABORTED FETUSES article Oct 01, 2019 American family clinics, such as the Planned Parenthood Institute, first help women stop pregnancy . And immediately after, with half-closed doors, a very profitable journey begins. The aborted fetus is dissected in different parts, liver, kidney, thyme, skin, which are sold. A liver can cost up to ... Read More |
PHARMA ECOMMERCE: WHAT IT TAKES TO WIN ONLINE article Sep 17, 2019 The pharma ecommerce question doesn’t end with distributors. In fact, pharma manufacturers, too, must carve out a place in the digital ecosystem. So what can pharmaceutical manufacturers do to improve their customer experience through ecommerce? The article brought up a lot of great points, bu... Read More |
FOUR STAND-OUT SKILLS YOU NEED TO MOVE INTO THE PHARMA INDUSTRY article Sep 16, 2019 The pharmaceutical industry is an exciting, fast-paced and ever-changing world to work in. I talk to pharmaceutical sales professionals daily, from Graduate Sales Representatives promoting ‘me too’ drugs, to Senior Sales Directors working on specialist rare disease products, and have a s... Read More |
YOUR CANCER TARGETS MAY NOT BE REAL article Sep 12, 2019 A paper from Cold Spring Harbor labs that invalidated MELK as a cancer target. That was straightforward enough: knocking it out via CRISPR across a whole range of cancer cell lines had no effect on their growth at all, so it’s kind of hard to make the case that it’s an important thing to... Read More |
VALUATION OF PHARMA COMPANIES: 5 KEY CONSIDERATIONS article Sep 10, 2019 Valuing pharma companies isn’t the same as valuing non-pharma companies, for several reasons. The life cycle of prescription drugs is relatively brief, with high-margin revenue falling to zero almost overnight when drug patents expire. Pharmaceuticals are high-growth, high-profit, and high-ris... Read More |
THE FUTURE OF PHARMA: HARNESSING AI TO DECENTRALISE DATA article Sep 09, 2019 Most tools and technologies that do advanced analytics or search, especially in pharma, force you to build a common repository for the data before any analytics can begin. This means one must invest in building something like a data warehouse or data lake first, then add your analytics engine on top... Read More |
5 STEPS TO SOCIAL MEDIA STRATEGY FOR PHARMA article Sep 05, 2019 With almost 2.7 billion social media users worldwide it is vital that pharmaceutical companies form a social media strategy. Social media has transformed the way both consumers and companies communicate and has become the norm across other industries creating an expectation for consumers and patient... Read More |
DEAL OR NO DEAL: HOW BREXIT IS IMPACTING PHARMA article Aug 30, 2019 At the time of writing, the United Kingdom (UK) is on its third deadline to leave the European Union (EU). What was deemed to be “the easiest trade deal in human history1” is now looking ever increasingly unlikely; and is beginning to cause anguish for not only the pharmaceutical industr... Read More |
THE PROMISE AND PITFALLS OF MOLECULAR TESTING IN ONCOLOGY article Aug 30, 2019 Great strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain that frustrate both physicians and patients. Central to this is how to use the large amounts of genetic data now available. Dr Chris Gaj explores the challenges and potential consequences f... Read More |
REAL WORLD EVIDENCE: A PHARMA-EVOLUTION article Aug 28, 2019 Smart devices and wearables are the norm of the day. We wake up in the morning to our watch reminding us of the number of steps to walk, the speed of our heart beats etc. The same watch vibrates if we are stationary at our work station, prompting us to move. There is a surge in health-related data g... Read More |
TOP THINGS TO CONSIDER BEFORE INVESTING IN PHARMA MACHINERY article Aug 26, 2019 Investment in pharma machinery requires lots of finance and efforts. Hence, the process needs to be very careful and considerate. There are numerous options in terms of make and models. Choosing the right one is difficult whether you buy a first-hand or a used machine. This post helps you to select ... Read More |
WHY A NO-DEAL BREXIT MEANS MORE FAKE PHARMA article Aug 21, 2019 Medicines are the most common medical intervention used across the UK and Europe. Unfortunately, falsified or fake medicines are entering global supply chains and have become a leading public health concern worldwide. It is, therefore, vital that there are systems in place to stop the manufacturing ... Read More |
FDA SENT THESE WARNING LETTERS TO PHARMA/DEVICE COMPANIES article Aug 20, 2019 We cover three drug warning letters, one issued to a compounding pharmacy, one device warning letter and one in the food area that is a ‘first of its kind’. One of the drug warning letters is issued to a firm that recovered solvents that were used in the manufacture of the API of valsart... Read More |
5 POTENTIAL IMPACTS THE PHARMA INDUSTRY SHOULD BE PLANNING FOR article Aug 19, 2019 The Pharmaceutical industry has an annual turnover of 41.8 billion pounds, providing 8.2 Percent of UK goods exported and collectively employing 113,000 people, and is thus a major contributor to the nations ability to care for an ageing population and support an uncertain economy. What challenges d... Read More |
UNDERSTANDING AND REMOVING THE BARRIERS TO PATIENT RETENTION article Aug 14, 2019 Each year, 1.89 billion dollars is spent on patient recruitment for clinical trials.1 With a 30 Percent average dropout rate across all clinical trials, many pharmaceutical companies are spending a large amount of money to recruit patients who arent staying enrolled in their trials. Read More |
AUTHORIZED GENERICS EXPLAINED article Aug 13, 2019 DRUGMAKERS LATEST GAMBIT EXPLAINED: DESIGNED TO EXTEND MARKET EXCLUSIVITY AND STIFLE OR DELAY COMPETITION, AUTHORIZED GENERICS CAN BE MORE PROFITABLE THAN BRAND. In 1984, the Hatch-Waxman Act established the modern generic drug business by establishing rules for safety and competition, including gra... Read More |
ADOPTION OF CLOSED LOOP MEDICINES ADMINISTRATION INTO THE NHS article Aug 08, 2019 Closed loop medicines administration (CLMA) is the functionality that supports the cross checking of the correct patient, medicine and prescription using digital technologies. Specifically, checking should be used to confirm the patient identity against the medicine/dose due and the actual medicine ... Read More |
SIX WAYS TO SURVIVE WORKING AS AN ON-CALL PHARMACIST article Aug 08, 2019 Working on call could be one of the most stressful parts of a pharmacists career, but it is also an essential part of a junior pharmacists training and a time during which you can learn the most. Clinical learning is at the forefront of most junior pharmacists minds, but it is the operational learni... Read More |
WHAT IS THE FUTURE OF CONTINUING MEDICAL EDUCATION CME? article Aug 07, 2019 In today’s knowledge-based society, health care professionals (HCPs) have a responsibility to continuously develop and refine their skills through lifelong learning. Academic institutes can foster such learning through programmes of continuing medical education (CME). But what is CME and why i... Read More |
HOW CAN TECHNOLOGY IMPROVE THE NARRATIVE FOR PHARMA? article Aug 07, 2019 The pharmaceutical and healthcare industries in the UK and across the world are facing a multitude of challenges. They are being challenged on how they differentiate themselves in a growing and crowded marketplace, how they engage with their audiences and how they remain innovative and relevant. Read More |
FUTURE OF PHARMA: BUILDING THE RIGHT ENVIRONMENT FOR AI SUCCESS article Jul 25, 2019 What does the future of pharma look like through the eyes of a technologists background? We were fortunate enough to find out at last month at our 2nd annual GNS Forum. Shahram Ebadollahi, PhD, MBA who is the Global Head of Data Science and AI at Novartis AG, joined us to share his thoughts on how t... Read More |
PHARMALITTLE: NEW RECORDS SHOW DRUG MAKERS OPIOID PUSH article Jul 24, 2019 Rise and shine, everyone, the middle of the week is already here. And a hazy, muggy morning is unfolding here on the Pharmalot campus this morning, where the officials mascot is noisily snoozing and one of the short people is sleeping in. As for us, we are downing yet another needed cup of stimulati... Read More |
GOOGLE AI COULD CHALLENGE BIG PHARMA IN DRUG DISCOVERY article Jul 21, 2019 A win for DeepMind, the AI arm of Google’s parent Alphabet, at a biennial biology conference could upend how drugmakers find and develop new medicines, according to Bloomberg. It could also dial up pressure on the world’s largest pharmaceutical companies to prepare for a technological ar... Read More |
WHY AI IS A PRACTICAL SOLUTION FOR PHARMA article Jul 18, 2019 Artificial intelligence, or AI, is gaining more attention in the pharma space these days. At one time evoking images from futuristic science fiction, it now plays a significant role in smartphones, cars, search engines, and financial transactions. But what, exactly, is artificial intelligence? It is... Read More |
NEED FOR PATIENT ENGAGEMENT IN PHARMA TODAY article Jul 18, 2019 Pharmaceutical and clinical industries are facing fierce demands from insurers, regulators, independent groups and consumers every day. In order to improve clinical trials and the drug discovery process, it is important to build better communication and links between all the stakeholders. This means... Read More |
|
THE 7 PRINCIPLES OF PHARMA CONTENT article Jul 17, 2019 In pharma, the sales process often starts with content, or a relationship may have started with some form of content. Great pharma content marketing follows a set of connected principles. Content marketing is the building of a narrative that looks to speak to target audiences, segments and personas ... Read More |
FDA SENT THESE WARNING LETTERS TO PHARMA/DEVICE COMPANIES. article Jul 16, 2019 There were six warning letter postings during this week: three drug warning letters including one regarding Akorn’s site in Somerset, NJ that the company announced a few weeks ago, one to a device manufacturer, one to an IRB, and one to a compounding pharmacy. Read More |
THE BENEFITS OF CLOSED-LOOP MARKETING FOR PHARMA COMPANIES article Jul 12, 2019 CLM has a huge impact on pharma companies, causing a major change in firm culture & ways of working, because of this new concept introduction. The idea is to create a virtuous circle between a target & a multi-channel digital marketing tool aimed for sales. CLM captures the Health Care Profe... Read More |
THE END OF AN ERA IN PHARMA article Jul 12, 2019 National Health Commission has just released the first version of its monitoring catalogue for rational drug use. This is the first national-level policy aimed to curb “irrational drug use”; previous attempts have been trial runs at the provincial and municipal levels. The policy monitor... Read More |
|
HOW DOES PHARMA LEARN TO SPEAK PATIENT? THE “PATIENT VOICE” article Jul 11, 2019 Before getting to the language of patients or “patient voice,” it is useful to understand that “we are not all patients.” Carolyn Thomas, writer and patient advocate, explains that, being a patient “sometime or other in life” is not the same thing as being a patie... Read More |
REAL-WORLD EVIDENCE IS WHAT PHARMA NEEDS NOW TO HELP CURE LUNG CANCER article Jul 11, 2019 Non-Small Cell Lung Cancer (NSCLC) is a designation that accounts for more than 80 percent of lung cancers diagnosed, and it has emerged as a new hotspot for investment by pharma manufacturers. Globally, the NSCLC therapeutics market is expected to rise to a valuation of US $15.1 billion by 2023, wi... Read More |
|
BURIED TREASURE – OF A SORT article Jul 10, 2019 A former colleague was telling me the other day about some not-so-pleasant surprises that occurred when he was helping to clean out a lab that hadn’t had some cabinets opened in a while, and I think many readers will have had such experiences. Academic labs are particularly prone to Easter egg... Read More |
SWEET ALMONDS: ONE AMINO ACID DID THE TRICK article Jul 08, 2019 Well, I spent the holiday weekend here sending out pictures of food on my Twitter account, so I suppose it’s only fitting that I blog about a related topic today. But it also touches on metabolic enzymes, transcription factors, and death by cyanide, so there’s something for most everyone... Read More |
CMS MANDATES PHARMA TO DISCLOSE DRUG PRICES article Jul 04, 2019 If you are watching television in the United States, you are more than likely to see at least one drug commercial. These direct-to-consumer ads, as the industry knows them, offer brief testimonials of a drug’s effectiveness and safety, but typically leave out the drug’s price. As a bold ... Read More |
AMA SAYS MATURE 12-YEAR-OLDS CAN CONSENT TO VACCINATION WITHOUT PARENTS article Jul 03, 2019 At the recently concluded annual meeting of the American Medical Association (AMA) in Chicago, AMA delegates adopted a doozy of a new policy. The powerful trade group agreed to develop model legislation that pressures state legislatures into allowing minors to "override refusenik parents on vac... Read More |
6 REASONS WHY ADVANCED ANALYTICS IS ESSENTIAL IN PHARMA article Jun 30, 2019 It’s no secret that technology has had a major impact not only on our daily activities, but also on businesses in almost every industry. The pharma industry, in particular, has seen major changes throughout many operations due to the implementation of technology. Technology such as Artificial ... Read More |
ABBVIE, ALLERGAN, UGH article Jun 26, 2019 News broke yesterday morning (first at the Wall Street Journal, I believe) that Abbvie has agreed to acquire Allergan. This is one of the larger pharma mergers of recent years, and regular readers of this site will have a pretty good idea of the sigh and roll of the eyes with which I greet it. I thi... Read More |
|
|
WHY LIFE SCIENCES COMPANIES SHOULD BE AWARE OF ITS BENEFITS article Jun 21, 2019 Compliance with regulatory standards does not mean that life sciences companies should ignore ISO standards. We all know that implementing a management system or operational excellence program into a life science company’s workflow isn’t without its costs. Read More |
5 WAYS CLINICAL RESEARCH CAN HELP YOU AND YOUR PRACTICE article Jun 21, 2019 Conducting clinical trials in one’s private practice—as opposed to hospitals or universities—has become more customary in clinical research. This trend is resulting in patients feeling more comfortable with participating in trials and is also providing physicians with unique benefi... Read More |
BIOANALYSIS AT ALLIANCE PHARMA article Jun 17, 2019 At Alliance Pharma, our large molecule mass spec group focuses primarily on two areas: protein characterization and low level quantitative bioanalysis. We take pride in our dedication to providing clients with all of the analytical information they need about their protein of interest, with agility ... Read More |
THE MANY BENEFITS OF CONTINUOUS MANUFACTURING article Jun 12, 2019 Continuous manufacturing is based on a number of requirements driven by the Pharmaceutical industry; quality, efficiency and speed to market being some of these. Bosch fulfilled these requirements when it released Xelum in 2017. The Xelum platform allows for faster development times and a reduced ri... Read More |
UNDERSTANDING CHEMISTRY OF BIOLOGICS CAN DRIVE INNOVATION IN PHARMA article Jun 07, 2019 The consequences of consuming synthetic drugs (chemicals) are aplenty. The instances of pharmacovigilance keep surfacing, and they tarnish brand value which has long-lasting impact for a pharmaceutical company. As a result, most players developing drugs for complex diseases have ventured into discov... Read More |
HEALTHY LIFESTYLE OR CHRONIC KIDNEY DISEASE:THE CHOICE IS YOURS! article Jun 03, 2019 Chronic kidney disease (CKD) is a growing health problem with an estimated prevalence of around 11.5%.Individuals with CKD are at high risk for progressive kidney failure. End-stage kidney disease leads to considerable human and financial costs with a 5-year survival rate of less than 50%. There are... Read More |
REGULATED CANNABIS INDUSTRY WOULD SPUR HEALTHCARE AGENDA article Jun 03, 2019 Hemp, the non-psychoactive breed of cannabis, is the most versatile crop known to humans with thousands of uses in industry. Cannabis oil relieves chronic pain in debilitating illnesses such as cancer in both children and adults. Countries are beginning to consider decriminalising and legalising can... Read More |
GENOCEA BIOSCIENCES ON TOP article Jun 02, 2019 Despite the index’s dip, a number of NASDAQ biotech and pharma stocks still had notable share price increases last week. In particular, Genocea Biosciences (NASDAQ:GNCA) spiked on its announcement that the Journal of Clinical Oncology chose the company’s GEN-009 clinical results to be pr... Read More |
HOW US SANCTIONS HINDER IRANIANS’ ACCESS TO MEDICINE article May 31, 2019 The United States has over the past four decades imposed a wide range of economic sanctions to punish Iran for a number of undesired policies. While Trump administration officials continue to insist that food and medicine are exempt from US sanctions, and that sanctions do not hurt the Iranian peopl... Read More |
COLD WARRIORS TANKED BIG PHARMA REGULATION article May 31, 2019 With prices climbing for lifesaving drugs like insulin, the regulation of Big Pharma is frequently in the news. Historian Dominique A. Tobbell writes that we’ve been having this debate since the 1950s. Back then, Senator Estes Kefauver, a Tennessee Democrat, became worried about the high price... Read More |
|
WHY PHARMA FRANCHISE IS A BOON FOR SMALL PHARMACEUTICAL COMPANIES? article May 30, 2019 Do you own a micro-sized or small company? If yes, then what business model do you think will be ideal when you aim at doing a profitable business?Ask anyone who is an expert in the niche, and you will get the answer, “pharma franchise business.” Statistics also prove the statement. Chec... Read More |
SCHUH TV DRUG ADS ENOUGH TO MAKE YOU SICK. article May 30, 2019 If everyone responded to TV drug ads’ prompts to “ask your doctor” or “check with your physician” about using the product, doctors likely would have no time to treat people. They’d be spending all their working hours answering questions. It used to be that the dog... Read More |
MATOKE PHARMA AND ANTIMICROBIAL RESISTANCE article May 29, 2019 Alan joined Matoke Pharma last year, having previous spent 35 years at Bayer, and he explained how that part of his career unfolded, from sales rep to antibiotics clinical research and then to global marketing and brand manager roles before ending with a series of senior management positions. Read More |
BIG PHARMA EMITS MORE GREENHOUSE GASES THAN THE AUTOMOTIVE INDUSTRY article May 29, 2019 More than 200 companies represent the global pharmaceutical market, yet only 25 consistently reported their direct and indirect greenhouse gas emissions in the past five years. Of those, only 15 reported their emissions since 2012.One immediate and striking result is that the pharmaceutical sector i... Read More |
NEW RULES FOR PHARMA IN LIFE SCIENCES article May 29, 2019 Pharma must deliver much more than drugs on the way to a more consumer-oriented industry. Attention on continuous R&D innovation M&A activities often are only one element of pharma companies to maintain or strengthen their position in changing markets. Given the number of changes and challen... Read More |
WHERE DRUGS COME FROM: A COMPREHENSIVE LOOK article May 28, 2019 On the roles of academia and industry in drug discovery. Which is a topic that refuses to go away. I am prepared to swear that before starting this blog I had no idea of how many people are convinced that the drug industry does little or no research, and that academic labs discover all the drugs. I ... Read More |
HISTORIC TRIAL TO WEIGH BIG PHARMA'S ROLE IN OPIOID EPIDEMIC BEGINS article May 28, 2019 Hope for the opioid crisis: It's no secret that opioid deaths and overdoses are at crisis levels in the US. However, 2019 may bring new ways of fighting this epidemic. Every year, the Cleveland Clinic releases the most important medical advancements for the coming year, and at the top of its lis... Read More |
COULD USING OLD MEDICATION KILL YOU? article May 27, 2019 Winter has arrived and with it colds and flu. If you’re thinking of using meds that have been in the cabinet for months don’t do it. Spokesperson for pharmaceutical company Pharma Dynamics Nicole Jennings says keeping unused medication is not advised as it can lead to misuse and accident... Read More |
PARTNERING FOR SUBLINGUAL SUCCESS article May 24, 2019 Oral drug delivery has maintained a position of strength within the bio/pharma industry for a number of years, yet challenges associated with oral delivery, such as the harsh conditions of the gastrointestinal tract and enzymatic breakdown, have given rise to the advancement of alternative approache... Read More |
|
MORE HACKS INEVITABLE IN PHARMA INDUSTRY, CYBERSECURITY EXPERT SAYSS article May 22, 2019 Earlier this month, sophisticated cyber thieves hacked into the databases of Charles River Laboratories and compromised some client data. Hacks like this have happened before and they are bound to happen again – perhaps sooner, rather than later.Andrew Douthwaite, chief technology officer for ... Read More |
|
CAN PHARMA SURVIVE AS DATA-DRIVEN THERAPY TAKES CENTRE STAGE? article May 08, 2019 Payment-by-outcomes and digital therapeutics (DTx) count among the serious challenges the pharma industry must negotiate in the coming years. They have the potential to change what healthcare industry reimburses. Rather than a drug alone, it will seek a package of drug, digital services and digital ... Read More |
GSK CHASES TRELEGY ASTHMA NOD WITH MIXED PHASE 3 RESULTS article May 03, 2019 With generics attacking Advair, GlaxoSmithKline has talked up prospects for 3-in-1 respiratory med Trelegy. Now, the company has data in hand that could help it move into the asthma arena—though it's not all positive. Thursday, GSK released phase 3 trial data showing Trelegy had topped Bre... Read More |
|
TARGETED PROTEOMICS: BENEFITS AND TECHNIQUES article Apr 24, 2019 The proteome of the cell genome is more insightful compared to its transcriptome as proteins directly determine and alter cellular function. Post‐translational modification of existing proteins, increased abundance or allosterically modulated protein conformations have been tied to complex diseases,... Read More |
BIG PHARMA CUTS, CURRENT AND COMING article Apr 22, 2019 Word came out just before the weekend (first at Endpoints) that GlaxoSmithKline is laying off R&D employees at both Stevenage (UK) and Upper Providence (US). Current leadership is re-organizing drug discovery efforts to put more emphasis on oncology, immunology and genetic-linked disease, and th... Read More |
VETTER’S SKOKIE FACILITY EXPANSION NEARS COMPLETION article Apr 16, 2019 Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) announced today that a significant level of expansion activities are nearing completion at its US clinical manufacturing facility located at the Illinois Science & Technology Park in suburban Chicago. The ongoi... Read More |
TAKEDA ADDS REINFORCEMENT TO ITS INVESTOR CHARM OFFENSIVE article Apr 16, 2019 Financing and creating enduring confidence around a deal like Takeda’s $62 million purchase of Shire. To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest min... Read More |
SUGAR ANALYSIS USING CHROMATOGRAPHY article Apr 15, 2019 The sensory and textural properties of foods can be attributed to monosaccharides, such as glucose, fructose, sucrose, and oligo and polysaccharides. The main difficulty while analyzing sugars is the variable isomeric forms that they can be present in. For example, glucose can be present in several ... Read More |
|
ORIGIN: THE PHARMA SUPPLY CHAIN OF THE FUTURE article Apr 15, 2019 In an industry that evolves every day, having first mover advantage is a must for any pharmaceutical manufacturer looking to compete. Knowledge, infrastructure and foresight are key to remain efficient and agile as the industry faces numerous forces which are reshaping and dictating the direction of... Read More |
BIG PHARMA: STOP DODGING TAXES! article Apr 12, 2019 A new report shows that the big pharma has enjoyed a whopping $7 billion tax cut in 2018 thanks to Trump’s new corporate-friendly tax rules. In just over a week’s time, Oxfam will be confronting Johnson & Johnson execs at the company’s big shareholder meeting -- and delivering ... Read More |
|
|
|
4 PHARMA COMPANIES SAVED $7 BILLION FROM GOP TAX LAW article Apr 09, 2019 Four pharmaceutical companies — Johnson & Johnson, Pfizer, Merck and Abbott Laboratories — collectively kept $7 billion in tax savings in 2018 due to Republicans' 2017 corporate tax overhaul, according to a new Oxfam report. The bottom line: Oxfam's results mirror our reporti... Read More |
HOW A SELF-LEARNING ONTOLOGY BENEFITS PHARMA AND LIFE SCIENCES? article Apr 03, 2019 Every domain has its own language. The same word used in different domains can have totally different meanings. In fact, the same word can mean two separate things for different subdomains, eg. in science, hedgehog is both animal and protein. Moreover, domain language is dominated by abbreviations a... Read More |
|
ADAMIS PHARMA SELLS EPINEPHRINE INJECTOR RIGHTS TO NOVARTIS article Jul 02, 2018 Adamis Pharmaceuticals is selling U.S. commercial rights to Symjepi, a competitor to Mylan’s EpiPen, to Novartis.Although financial details were not released, Novartis’ Sandoz division will pay Adamis an upfront fee and various performance-based milestone payments. Net profits in the U.S... Read More |
SINO-AMERICAN PHARMA PROS DRAWS CHINA, U.S. DRUGMAKERS TO PHILLY article Jun 25, 2018 In a cheerful cacophony of start-up and recruiter pitches, emerging-science talks and investment-banking tips, laptop displays and card exchanges in English and in Mandarin more than 1,000 Philadelphia-area scientists, pharma professionals, and people who want to do business with them jammed a hotel... Read More |
PHARMA COMPANIES SECURE ABOUT $250 MILLION IN FINANCING TODAY article Jun 19, 2018 Venture capitalists are flexing their muscles today with the significant support of pharma and biotech companies. Approximately $250 million in financing has been secured to support various pipelines to address multiple concerns. Boston-based Decibel Therapeutics secured $55 million in a Series C fi... Read More |
|
HOW PHARMA HIDES DATA ABOUT FARM ANTIBIOTIC USE article Jun 11, 2018 ON Wednesday last week, the non-profit Natural Resources Defense Council revealed that pig herds in the United States receive almost as many antibiotics as people in this country do. That’s bad news, especially since most of the pigs receiving antibiotics aren’t sick, but instead are get... Read More |
MADRIGAL PHARMA MORE THAN DOUBLES AFTER LIVER DRUG STUDY SUCCESS article May 31, 2018 Madrigal Pharmaceuticals Inc’s shares more than doubled after mid-stage trial data showed its lead drug reduced liver fat in patients with fatty liver disease, placing it ahead of larger rivals to tap into a potential market worth $30 billion.Often dubbed the “silent disease” becau... Read More |
DECODING THE DEADLY NIPAH VIRUS article May 28, 2018 A virus named after Kampung Sungai Nipah, a village in Malaysia, where it was first discovered in 1998-99. The virus, that eventually killed 105 people in Malaysia, was first suspected to be Japanese encephalitis (JE) which, like the Nipah virus, induces brain inflammation. According to a paper by D... Read More |
|
HOW BIG PHARMA FORCES US TO BUY DRUGS INSTEAD OF CANNABIS article May 23, 2018 Simply put, Big Pharma has been a long time opponent of legalizing medical marijuana as it threatens to ruin its business and drop the market cap for pharmaceutical drug companies.Even though medical cannabis has been legalized in more than half of the US states, all of Canada and in Mexico, prices ... Read More |
|
|
BIG PHARMA FUNDS OPIOID TRAINING. WHAT COULD GO WRONG? article May 12, 2018 The ‘Global and Chinese Nasal Drug Delivery Technology Industry, 2013-2023 Market Research Report’ is a professional and in-depth study on the current state of the global Nasal Drug Delivery Technology industry with a focus on the Chinese market. The report provides key statistics on the... Read More |
FG CODEINE BAN, EMZOR PHARMA CLOSURE A KNEE JERK RESPONSE – EXPERTS article May 09, 2018 The recent ban on codeine-containing cough syrup by the Federal Government, shutting down Emzor Pharmaceuticals Ind. Ltd., Peace Standard Pharmaceutical Limited and Bioraj Pharmaceutical Limited is a knee jerk response to the drug abuse problem experts have said. The ban is echoing in the public spa... Read More |
|
OREXIGEN OPENS BIDDING PROCESS, SELLING ITSELF FOR $75 MILLION article Apr 25, 2018 To continue reading this article and to access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space you need to be logged into the site and have an active subscription or trial subscription. Please login or subscribe in order ... Read More |
|
ALLIANCE PHARMA SELLS CHINESE BUSINESS FOR £2.9 MILLION article Apr 17, 2018 Wiltshire-based Alliance Pharma, the specialty pharmaceutical group, have announced that it has agreed to sell its 60% interest in non-core Unigreg Limited to its joint venture partner, Pacific Glory Development Limited, for £2.9 million. Unigreg owns the rights to Forceval, a micro-nutrient s... Read More |
PHARMA FIRMS COULD REPORT WEAK NUMBERS article Apr 09, 2018 The troubled pharma sector is expected to report weak Q4FY18 numbers, with their profit after tax (PAT) likely to decline by 9 per cent year-on-year (YoY) and rupee appreciation may put pressure on their realisations, industry analysts said. Edelweiss research analyst Deepak Malik said the firm expe... Read More |
TRADING BIG PHARMA FOR SMALL STARTUP article Apr 08, 2018 After speaking with at least a half-dozen C-suite level executives who made the leap from big pharma to lesser-known startup or biotech companies, it’s very clear that there is something deep down in their personalities that propelled them to make the move. Some of them were at the top of thei... Read More |
HOW BLOCKCHAIN CAN IMPROVE THE PHARMA MANUFACTURING SUPPLY CHAIN article Apr 06, 2018 The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the regulated medicines on the pharmacy shelves. It has been one of the top industry performers of the past three decades. By maintaining the highest safety and qual... Read More |
|
PHARMA OCEAN FREIGHT ENTERS NEW WATERS article Mar 28, 2018 A new integrated ocean freight program for pharmaceuticals aims at a new approach to pharma-logistics fulfillment. The Posiedon project seeks to harness the collective knowledge of the supply chain to drive innovation, efficiencies, and safety and save money. “It’s the difference between... Read More |
HOW CAN THE PHARMA INDUSTRY HELP THE HOMELESS? article Mar 23, 2018 In January I published, “Can JPM And BTS Make A Bigger Difference?” This was part one of a four-part blog series on my experience of attending this year’s J.P. Morgan Healthcare (JPM) and Biotech Showcase (BTS) conferences in San Francisco. In this particular blog, I wrote about th... Read More |
BAYER LOOKS TO LEVERAGE AI ACROSS THE PHARMA VALUE CHAIN article Mar 21, 2018 Bayer has already shown more than a passing interest in artificial intelligence through its digital accelerator programme Grants4Apps, but the company’s use of the technology looks to be more wide-ranging and deep-seated than that. Talking to journalists after the company’s Financial New... Read More |
COULD A PHARMA COMPANY SHUN SALES REPS AND BE SUCCESSFUL? article Feb 26, 2018 Matt Lowe, pharma agency veteran and founder (just this week) of healthtech agency performance.io, believes that such a company, relying heavily on search and performance marketing, may be a possiblity in the next few years (albeit once somebody has the courage to take the leap). I spoke to Lowe abo... Read More |
WHAT HAPPENED TO THE PLANS FOR A SMART CONTACT LENS FOR DIABETICS? article Jan 25, 2018 Originally projected to be on the market by 2020, excitement about the contact lens to measure glucose levels from Novartis and Google has waned. Why? In 2016, smart wearables growth was steady but a recent study predicts that the market will pick up this year introducing innovative products to the ... Read More |
|
|
PHARMA COMPANIES' EFFORTS TO ADDRESS DRUG-RESISTANT INFECTIONS article Jan 23, 2018 An independent analysis of pharmaceutical industry efforts to tackle drug resistance finds that, as well as developing new drugs, companies are also dismantling the incentives that encourage sales staff to oversell antibiotics, setting limits on the concentration of antibiotics in factory wastewater... Read More |
HOSPITALS MAKING DRUGS? article Jan 19, 2018 This story from the New York Times got a lot of attention yesterday, and understandably so. It’s fundamentally about the shortage of some generic drugs, a problem that’s been with us for some years now in one form or another. My own belief is that much of this is a regulatory problem, an... Read More |
A CURE FOR CANCER? HOW CAR-T THERAPY IS REVOLUTIONIZING ONCOLOGY article Jan 16, 2018 CAR-T therapy has been hailed as a cure for cancer, but what really is this “miraculous technology” and what can we actually expect from it? The field of immuno-oncology is booming with billions of euros in investment. The ability to rewire our own immune system to fight cancer has certa... Read More |
REGULATORS ADJUST TO BETTER MEET PHARMA MARKET NEEDS article Jan 16, 2018 Christine M. V. Moore, Ph.D., Global Head and Executive Director, Merck & Co-led “Changes in the Regulatory Landscape,” an education session held 31 October during the 2017 ISPE Annual Meeting & Expo. The first speaker, Ellen F. Morrison, Assistant Commissioner of Medical Product... Read More |
WHY YOU SHOULD WORK FOR A PHARMA START-UP article Jan 04, 2018 If we look at Aerie Pharmaceuticals and their new products Rhopressa and Roclatan, these are designed to reduce elevated intraocular pressure (IOP), the cause of vision loss in open-angle glaucoma. This is the largest prescription market in ophthalmology and it’s amazing to see such a breakthr... Read More |
PHARMA STARTUP COMBINES AI WITH CELL IMAGES TO TARGET DISEASE article Jan 04, 2018 For centuries, modern medicine has grappled with the problem of finding the right drug treatment for the correct disease. While incremental progress is made every year, the lag time and expense of bringing a drug successfully to market have frustrated doctors, scientists, and patients. In search of ... Read More |
CRITICAL CARE: NEW GUIDANCE FOR MEDICATION SAFETY IN THE ICU article Dec 11, 2017 The Society of Critical Care Medicine (SCCM) is committed to “Right Care, Right Now.”As part of this commitment, SCCM identifies patient care needs that require evidence-based best practice guidelines and works with experts to advance practices. Earlier this year, we published” Cli... Read More |
SOCIAL MEDIA INFLUENCERS IN HEALTHCARE AND PHARMA: WHAT’S THEIR ROLE? article Dec 04, 2017 Looking to social media influencers for advice makes sense when you’re shopping for fashionable jeans, your next great vacation, or even inspiration for your fitness regime. Most retail brands agree. According to the research firm L2 Gartner, 70% of retail brands are working with influencers t... Read More |
|
|
A PRACTICAL APPROACH TO THE CHALLENGES OF PEDIATRIC DRUG DEVELOPMENT article Nov 17, 2017 Drug developers can’t take an adult clinical trial protocol and simply retool it for pediatrics. Yet, in my work at a pediatric clinical research organization (CRO), I frequently see sponsors attempt to do just that. Successfully implementing a pediatric drug development plan poses challenges ... Read More |
THE CONVERGENCE OF DIGITAL HEALTH, DEVICES AND PHARMA article Nov 15, 2017 There has been a huge push in policy circles to speed innovation in medicine which is manifest in several initiatives, including most notably the 21st Century Cures Act implementation. But it would be a mistake to assess the quickening pace of innovation solely through the lens of policy. Read More |
ENCOURAGE YOUR PATIENTS TO BE ACTIVE PARTICIPANTS article Nov 14, 2017 Patient engagement has all the intentions to improve the ability of every patient to create meaningful and solid relationships with their healthcare providers. When patients can have meaningful relationships with their healthcare providers, this will create the way for them to participate actively w... Read More |
PHARMA IN THE DIGITAL AGE article Nov 14, 2017 We are living in a digital age, and this results in more patients being less depending on their health care providers for advice and information. More patients are now able to take more control of their lives and their health. Read More |
GOVERNMENTS MOUNT OPIOID LAWSUIT WAVE AT PURDUE PHARMA article Nov 10, 2017 Governments are swamping Purdue Pharma, makers of OxyContin, with opioid lawsuits alleging the company is responsible for the costs of opioid overdose.The continuing wave of opioid lawsuits coming at the makers of OxyContin, Purdue Pharma, based in Stamford, Connecticut, is growing. Recently, 28 Wis... Read More |
COMPLEX GENERIC DRUG PRODUCTS: A CHANGING REGULATORY LANDSCAPE article Nov 01, 2017 Earlier this year, the U.S. Food and Drug Administration (FDA) announced its Drug Competition Action Plan, which aims to bring more competition to the drug market and improve consumer access to drugs. As part of this effort, the Agency is focusing on ways to help bring complex generic drugs to marke... Read More |
|
DID AMAZON JUST CREATE A SOLUTION TO PHARMA’S LAST MILE PROBLEM? article Oct 31, 2017 Amazon just announced a new program that would allow delivery people into a person’s house. While this may help solve the problem of items being stolen off people’s porches and could make delivery of items that require signatures such as iPhones easier, it may also be another piece to Am... Read More |
WHAT'S NEXT FOR INHALED MEDICATIONS AND INHALATION TECHNOLOGY? article Sep 11, 2017 Current estimates suggest that as many as 235 million people worldwide have asthma and over 200 million people have the chronic obstructive pulmonary disease (COPD). With rates set to increase, the need for efficacious medications for these incurable diseases is a major focus for research. Read More |
|
|
REFINING VALUE IN PHARMA article Jul 21, 2017 In every facet of life, the concept of value is at play. Individuals make their own assessment of value and that shapes a host of decisions from what to buy and where to buy it. For drugs, the difference is often that the individual needs to rely on someone else’s assessment. Read More |
CHANGES IN THE MEDICAL DEVICES REGULATION AFFECT DRUG DELIVERY DEVICES article Jul 10, 2017 Article 117 of the Medical Devices Regulation (MDR) (Regulation (EU) 2017/745) amends the Directive on medicinal products for human use (MPD) (Directive 2001/83/EC). This will significantly affect pharmaceutical manufacturers supplying drug delivery devices in combination with their medicinal produc... Read More |
WHEN DOCTORS TURN SALESPERSONS FOR LITTLE-KNOWN PHARMA COMPANIES article Jul 06, 2017 After delivery at a maternity and nursing home in Borivali, Mumbai, the patient’s husband was handed over a prescription by the doctor. The three medicines prescribed happened to be of a little-known Nagpur based pharma company and were priced much higher than the same ones produced by reputed... Read More |
ALL THINGS PHARMACEUTICAL article Jun 27, 2017 The White House recently launched a task force aimed at addressing the nation’s opioid addiction crisis, headed by New Jersey Gov. Chris Christie.1 According to the U.S. Department of Health & Human Services, the majority of drug overdose deaths that occur today involve an opioid. Prescrip... Read More |
HRA PHARMA TAKES TO SOCIAL MEDIA TO SUPPORT ITS ELLAONE BRAND article Jun 07, 2017 HRA Pharma has launched its emergency contraceptive brand on social media, setting up new UK-focused channels on for ellaOne on Facebook and Twitter. The Paris-headquartered pharma company hopes the move will help it ‘address the need for accurate online information’, while also breaking... Read More |
THE FALSIFIED MEDICINES DIRECTIVE (FMD) 2011/62/EU article May 30, 2017 Counterfeit drugs entering the European supply chain pose a significant health and safety threat to patients. Furthermore, the European Union Intellectual Property Office (EUIPO) estimates that the legitimate industry loses approximately €10 billion of revenue annually due to the presence of counter... Read More |
|
WHEN SPECIALTY DRUGS ARE NO LONGER IN THE MINORITY article Sep 02, 2016 One of the areas of greatest concern for pharmacy practice, in terms of both cost and impact on patient care, is the increasing development of pharmaceuticals that could be classified as “specialty.” While there is no universally accepted definition of a specialty drug, most characteriza... Read More |
PHARMA M&A IS ON FIRE AND AI IS THE GASOLINE article Jun 17, 2012 A perfect storm is brewing in pharma M&A. Reduced R&D productivity, comparative advantages of large pharma companies, and the Trump Administration’s tax cuts make M&A more attractive than usual for an already acquisitive industry. To navigate these waters, pharma giants must embrac... Read More |
MAKING MEDICINES AFFORDABLE: A NATIONAL IMPERATIVE A REVIEW article Today the National Academies of Sciences, Engineering, and Medicine released its report Making Medicines Affordable: A National Imperative. The charge of the committee was to “address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations th... Read More |
|
CANCER GROWTH HALTED BY CUTTING OFF NUTRIENT SUPPLY article Researchers are investigating how cancer cell growth can be curbed by disrupting their access to certain nutrients. Because our normal, healthy cells rely on the 24-hour cycle of our body to regulate the production of nutrients, the scientists were able to exploit that system and use it against glio... Read More |
|
|
|